Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia-Reference-Cited by-同舟云学术

Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia

Published:2015-12-21 Issue:5 Volume:12 Page:577-589
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Llorens Franc¹²,Schmitz Matthias¹,Karch André³,Cramm Maria¹²,Lange Peter¹,Gherib Kerim¹,Varges Daniela¹,Schmidt Christian¹,Zerr Inga¹²,Stoeck Katharina¹

Affiliation:

1. Clinical Dementia Center Department of Neurology University Medical Center Göttingen Göttingen Germany

2. German Center for Neurodegenerative Diseases (DZNE) Göttingen Germany

3. Department of Epidemiology Helmholtz Centre for Infection Research Braunschweig Germany

Funder

EU Joint Programme – Neurodegenerative Disease Research

European Commission

Federal Ministry of Education and Research

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2015.10.009

Reference48 articles.

1. Blood–brain-barriers in aging and in Alzheimer’s disease

2. CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings

3. Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

4. The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimerʼs disease

5. Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the EUROIMMUN automated chemiluminescence immunoassays for measurement of four core biomarkers for Alzheimer’s disease in cerebrospinal fluid;Practical Laboratory Medicine;2024-08

2. Potential Biomarkers in Cerebrospinal Fluid and Plasma for Dementia;Journal of Alzheimer's Disease;2024-07-16

3. Alzheimer's disease biomarker utilization at first referral enhances differential diagnostic precision with simultaneous exclusion of Creutzfeldt‐Jakob disease;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-01

4. Diagnosis in Scrapie: Conventional Methods and New Biomarkers;Pathogens;2023-11-28

5. Overview of the blood biomarkers in Alzheimer's disease: Promises and challenges;Revue Neurologique;2023-03